TNF Pharmaceuticals acquires LPU Holdings LLC for Series I Preferred Stock plus contingent milestones

Q/C TECHNOLOGIES, INC.

TNF to acquire 100% of LPU Holdings LLC; closing consideration is Series I Convertible Preferred Stock convertible into 747,362 common shares.
Contingent milestone payments include 6.25%/5% of equity offering proceeds up to $50M and a one-time share payment representing 10% of fully diluted shares upon reaching $50M aggregate proceeds.
Additional $1.75M payment (cash/equity) if TNF market cap reaches $100M for 10 consecutive trading days after 90 days post-closing.
Concurrent equity offering of at least $7.5M at $5.00/sh (Series H preferred) is a condition to closing.
Acquisition includes a License Agreement with LightSolver Ltd. for technology rights.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.